ArticleImmunoTargets and therapy2025

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia - Case Report.

Ibrahim Zoubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.